Researchers assessed the safety and efficacy of suzetrigine, a non-opioid pain signal inhibitor, on moderate to severe acute pain from in patients with surgical and nonsurgical pain.

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

The Food and Drug Administration (FDA) has approved Abrysvo ® (respiratory syncytial virus [RSV] vaccine) for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by ...

In a recent study, mean sensitivity was 85.5% and specificity 87% for detection of clear-cell renal cell carcinoma ...

Investigators studied cardiotoxicities of first-line regimens for metastatic hormone-sensitive and nonmetastatic castration-resistant prostate cancer.

The latest cases fuel growing concern among public health experts that an ongoing bird flu outbreak that is sickening dairy cows and poultry will eventually trigger human-to-human transmission of the ...

Patients in highest quintile of Social Vulnerability Index less likely to receive thrombolysis, mechanical thrombectomy ...

Based on their findings, the USPSTF recommends providing or referring to interventions that support breastfeeding for pregnant and postpartum persons. HealthDay News — The US Preventive Services Task ...

Mainly after the second cycle (19 of 25), paracentral ring-like subepithelial deposits, corneal haze, and filamentous keratitis occurred. HealthDay News — For patients receiving mirvetuximab ...

HealthDay News — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online October 14 in the Journal of the American Medical Association.

The prevalence of obesity continues to remain high in the US making the demand for effective treatments even more urgent.

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to ...